CommercialPrior AuthMedium impact
Atopic Dermatitis
Blue Cross & Blue Shield of Mississippi·MS · Dermatology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their atopic dermatitis policy requiring prior authorization for Adbry, Cibinqo, Eucrisa, Opzelura, and Rinvoq. The policy includes specific age requirements, quantity limits, and step therapy requirements with topical treatments before approval of systemic medications.
Action Required
Immediately: Billing team must implement prior authorization requirements for atopic dermatitis medications (Adbry, Cibinqo, Eucrisa, Opzelura, Rinvoq) for BCBS Mississippi members. Update system to flag these medications and alert providers to obtain PA before prescribing. Ensure documentation includes age verification, disease severity, prior treatment failures, and body surface area involvement as required by policy criteria.